TickerFacts.

A business in context

VYGR research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-08-06 · 0001640266-26-000007 · Items 2.02,9.01

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001640266-26-000006

  3. 8-K · Current report

    Report date 2026-07-13 · 0001104659-26-082906 · Items 8.01

  4. 4 · Ownership change

    Report date 2026-06-09 · 0001104659-26-072934

  5. 4 · Ownership change

    Report date 2026-06-09 · 0001104659-26-072927

  6. 4 · Ownership change

    Report date 2026-06-09 · 0001104659-26-072926

  7. 4 · Ownership change

    Report date 2026-06-09 · 0001104659-26-072924

  8. 4 · Ownership change

    Report date 2026-06-09 · 0001104659-26-072923

  9. 4 · Ownership change

    Report date 2026-06-09 · 0001104659-26-072922

  10. 4 · Ownership change

    Report date 2026-06-09 · 0001104659-26-072921

  11. 4 · Ownership change

    Report date 2026-06-09 · 0001104659-26-072919

  12. 8-K · Current report

    Report date 2026-06-09 · 0001104659-26-072324 · Items 5.03,5.07,9.01

  13. 8-K · Current report

    Report date 2026-06-01 · 0001104659-26-068591 · Items 8.01

  14. 8-K · Current report

    Report date 2026-05-07 · 0001104659-26-057115 · Items 2.02,9.01

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001104659-26-057097

  16. DEF 14A · Proxy statement

    Report date 2026-06-09 · 0001104659-26-050297

  17. 8-K · Current report

    Report date 2026-04-15 · 0001104659-26-045997 · Items 5.02

  18. 8-K · Current report

    Report date 2026-03-09 · 0001104659-26-025201 · Items 2.02,9.01

  19. 10-K · Annual report

    Report date 2025-12-31 · 0001104659-26-025197

  20. 8-K · Current report

    Report date 2026-02-09 · 0001104659-26-013897 · Items 5.02,8.01

  21. 8-K · Current report

    Report date 2026-01-08 · 0001104659-26-001955 · Items 7.01,9.01

  22. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001104659-25-108846

  23. 8-K · Current report

    Report date 2025-11-10 · 0001104659-25-108841 · Items 2.02,9.01

  24. 8-K · Current report

    Report date 2025-09-02 · 0001104659-25-085977 · Items 7.01,9.01

  25. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001558370-25-010511

  26. 8-K · Current report

    Report date 2025-08-06 · 0001558370-25-010507 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2025-06-03 · 0001104659-25-056835 · Items 5.02,5.07,9.01

  28. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001558370-25-006484

  29. 8-K · Current report

    Report date 2025-05-06 · 0001558370-25-006482 · Items 2.02,9.01

  30. DEF 14A · Proxy statement

    Report date 2025-06-03 · 0001558370-25-005254

  31. 10-K · Annual report

    Report date 2024-12-31 · 0001558370-25-002703

  32. 8-K · Current report

    Report date 2025-03-11 · 0001558370-25-002702 · Items 2.02,9.01

  33. 8-K · Current report

    Report date 2025-02-11 · 0001104659-25-011155 · Items 8.01

  34. SC 13G/A · Ownership disclosure

    0001172661-24-005316

  35. SC 13G/A · Ownership disclosure

    0000935836-24-000721

  36. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001558370-24-015304

  37. 8-K · Current report

    Report date 2024-11-12 · 0001558370-24-015299 · Items 2.02,9.01

  38. 8-K · Current report

    Report date 2024-09-03 · 0001104659-24-097152 · Items 1.01

  39. SC 13G/A · Ownership disclosure

    0001086364-24-008406

  40. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001558370-24-011073

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 1 transaction rows1SGrant / award: 10 transaction rows10AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

11 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-09
2026-06-11
SCANGOS GEORGE AA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
30000.00.0
2026-06-09
2026-06-11
MACKEY CATHERINE JA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
30000.00.0
2026-06-09
2026-06-11
Hyman StevenA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
30000.00.0
2026-06-09
2026-06-11
Vitale NancyA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
30000.00.0
2026-06-09
2026-06-11
Higgins Michael JA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
30000.00.0
2026-06-09
2026-06-11
Onyia JudeA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
30000.00.0
2026-06-09
2026-06-11
GERAGHTY JAMES AA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
30000.00.0
2026-06-09
2026-06-11
Colon GraceA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
30000.00.0
2026-06-09
2026-06-11
PIERCE GLENNA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
30000.00.0
2026-04-02
2026-04-03
Sandrock Alfred
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock11511.03.87
2026-04-01
2026-04-03
Shiferman Gregory L.A · Grant / award
Acquired
Common Stock50000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001640266Voyager Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Voyager Therapeutics (United States) · alias · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$80.00M$85.16M
2023-12-31$250.01M$273.96M
2022-12-31$40.91M$46.67M
2021-12-31$37.41M$46.10M
2020-12-31$171.13M$220.79M
2019-12-31$104.39M$136.34M
2018-12-31$7.62M$10.13M
2017-12-31$10.13M$13.81M

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗